Treating breakthrough pain in oncology.

@article{Mercadante2018TreatingBP,
  title={Treating breakthrough pain in oncology.},
  author={Sebastiano L Mercadante},
  journal={Expert review of anticancer therapy},
  year={2018},
  volume={18 5},
  pages={
          445-449
        }
}
INTRODUCTION Breakthrough cancer pain (BTcP) is an episode of severe intensity in patients receiving an adequate treatment with opioids able to provide at least mild analgesia. BTcP is a heterogeneous condition as episodes vary between individuals. The aim of this article is to review the pharmacologic options for the management of BTcP. Areas covered: Recent reviews revealed that transmucosal preparations of fentanyl provided superior and more rapid pain relief as compared to placebo and oral… CONTINUE READING
BETA
4
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 38 REFERENCES

°° Authoritative review of the developments of BTcP along 25 years

Pain
  • 2016